InnovAge Holding Corp. (NASDAQ: INNV) saw its stock price plummet 6.56% in pre-market trading on Wednesday, following the release of its fiscal 2025 fourth-quarter financial results. The significant drop suggests that the earnings report fell short of investor expectations, potentially indicating disappointing financial performance or guidance.

While specific details of the earnings report were not immediately available, the market's negative reaction implies that InnovAge Holding may have failed to meet analyst projections or provided a less optimistic outlook than anticipated. The healthcare services company, which focuses on providing comprehensive care for seniors, has likely faced challenges that have impacted its financial performance or future prospects.

Adding to the pressure on InnovAge's stock, both Goldman Sachs and William Blair maintained their Hold ratings on the company. Goldman Sachs set a price target of $5.50, while William Blair did not specify a target price. These neutral stances from major analysts, combined with the disappointing earnings results, appear to have contributed to the significant pre-market selloff. Investors will be closely watching for more detailed analysis of InnovAge's earnings report and any guidance provided by the company to better understand the factors driving this sharp decline.